BillionToOne

About

BillionToOne is a precision diagnostics company focused on genetic testing for disease detection.

Menlo Park,California,United States
101 - 250
https://www.billiontoone.com

Highlights

Details

Last Funding Type: Debt Financing
Last Funding Money Raised: $35M
Industries: Biotechnology,Genetics,Health Diagnostics,Medical
Founded date: Jan 1, 2016
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: BillionToOne, Inc.

BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to make pre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting with developing countries.

BillionToOne was founded in 2016 and is headquartered in Menlo Park, California.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

9

$295.90M

BillionToOne has raised a total of $295.90M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2022 from a Debt Financing round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 15, 2022	Debt Financing	$35M	1	Bridge Bank	—	Detail
Dec 15, 2022	Series C	$48.50M	8	—	—	Detail
Mar 30, 2022	Series C	$125M	11	Adams Street Partners Hummingbird Ventures	—	Detail
Jun 15, 2021	Series B	$55M	8	Hummingbird Ventures	—	Detail
Mar 10, 2020	Series A	$15M	12	Hummingbird Ventures Neotribe Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

8

25

BillionToOne is funded by 25 investors. Bridge Bank and Adams Street Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Bridge Bank	Yes	Debt Financing
Adams Street Partners	—	Series C
Baillie Gifford	—	Series C
Fifty Years	—	Series C
Hummingbird Ventures	—	Series C
Libertus Capital	—	Series C
Neotribe Ventures	—	Series C
Norwest Venture Partners	—	Series C
TIME BioVentures	—	Series C
500 Global	—	Series C